SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
758Characterization of a Large, Stable, High Copy Number Streptomyces Plasmid That Icebrg-12/6/2006
757I just perused the San Antonio Breast Cancer Symposium and the only thing that IVanBio-11/28/2006
756Ariad and Wyeth have mTOR inhibtor's which appear to synergize with 17-AAG: tuck-11/27/2006
755>>17-aag also synergizes with taxol, Keryx' UCN-01, and some Lilly drutuck-11/24/2006
754I agree, if you look at the major partnerships/acquisitions two out of the threeVanBio-11/21/2006
753It seems to me that the potential acquirer would be looking for synergy between tuck-11/21/2006
752Millenium makes sense to me as a partner or as an aquirer, but there could be a VanBio-11/20/2006
751>>MycoGrab<< No idea yet if it will work in cancer, but looks a goodnigel bates-11/20/2006
750Ah, yes; thanks for the reminder about MycoGrab. Hard to say what MLNM might rituck-11/20/2006
749>>That leaves Kosan and Infinity battling for the lead, with Vernalis/NVS nigel bates-11/20/2006
748Oh, I was just squawkin'. After the 3 months I gave it I'll probably givkeokalani'nui-11/19/2006
747>>I'm giving kosan 3 months to sell the company or partner hsp90 or I&tuck-11/19/2006
746Message 23024981 Cheers, Praveendr.praveen-11/18/2006
745>>Though the number of compounds in development for MM is mind-boggling.&gIcebrg-11/18/2006
744[Antiangiogenic Properties of DMAG, An Orally Bioavailable Heat Shock Protein 90tuck-11/18/2006
743The NCI guys are doing a lot of heavy lifting for Kosan and Infinity with respectuck-11/17/2006
742[HSP70 induction as part of the stress response may contribute to resistance to tuck-11/17/2006
741Kosan Presents Encouraging Antitumor and Safety Data on Novel Epothilone KOS-158mopgcw-11/10/2006
740kosn one of the few in the red today. Bad sign.keokalani'nui-11/6/2006
739Personally, I was hoping for the confusion lift today on the KOS(P) deal <g&gFiloF-11/6/2006
738[PDGFR alpha is destabilized by geldanamycins in cancer cells] >> J Biol tuck-11/4/2006
737I'm giving kosan 3 months to sell the company or partner hsp90 or I'm gokeokalani'nui-11/2/2006
736Kosan Appoints Robert De Jager as Chief Medical Officer 4:00 PM EDT October 26, mopgcw-10/27/2006
735Kosan Announces Third Quarter 2006 Financial Results and Highlights Thursday Octmopgcw-10/27/2006
734[Meanwhile, back in the lab they are still sort of struggling]. Precursor-dIcebrg-10/14/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News